Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01261975
Other study ID # 607
Secondary ID
Status Completed
Phase Phase 4
First received December 15, 2010
Last updated January 24, 2012
Start date August 2009
Est. completion date July 2010

Study information

Verified date January 2012
Source Bausch & Lomb Incorporated
Contact n/a
Is FDA regulated No
Health authority European Union: European Medicines Agency
Study type Interventional

Clinical Trial Summary

The objective of this study is to test the hypothesis that the time to reach a stable refraction is significantly shorter in eyes operated with the 1.8 mm coaxial microincision compared to eyes operated with the 2.75 mm standard incision using the Stellaris Vision Enhancement System.


Recruitment information / eligibility

Status Completed
Enrollment 36
Est. completion date July 2010
Est. primary completion date April 2010
Accepts healthy volunteers No
Gender Both
Age group 50 Years and older
Eligibility Inclusion Criteria:

- Subjects must be undergoing bilateral primary in-the-bag intraocular lens (IOL) implantation for the correction of aphakia.

- Subject's ocular media must be clear except for the presence of the cataract in both eyes.

Exclusion Criteria:

- Subject with any disease, which, in the Investigator's opinion, might interfere with the conduct of the study.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment


Related Conditions & MeSH terms


Intervention

Procedure:
Coaxial Micro-Incision Cataract Surgery
1.8 mm coaxial micro incision
Coaxial Small Incision Cataract Surgery
2.75 mm coaxial incision

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Bausch & Lomb Incorporated

Outcome

Type Measure Description Time frame Safety issue
Primary Refractive Stability Cumulative portion of eyes achieving refractive stability within 0.5 D of the final value for the remainder of the trial by surgical procedure and visit. 12 weeks No
Secondary Best Corrected Visual Acuity Best corrected distance visual acuity(BCVA) was assessed using logMAR charts. Change from preoperative visit summarized by visit. A minus change represents an improvement of the visual acuity Visit 1, visit 2, visit 3, visit 4 No
Secondary Best Corrected Visual Acuity Best corrected distance visual acuity(BCVA) was assessed using logMAR charts. Change from baseline summarized by visit. A minus change represents an improvement of the visual acuity. visit 5, visit 6, visit 7, visit 8 No
Secondary Uncorrected Visual Acuity Uncorrected visual acuity(UCVA) was assessed using logMAR charts. Change from baseline summarized by visit. Visit 1, visit 2, visit 3, visit 4 No
Secondary Uncorrected Visual Acuity Uncorrected visual acuity(UCVA) was assessed using logMAR charts. Change from baseline summarized by visit. visit 5, visit 6, visit 7, visit 8 No
Secondary Surgically Induced Astigmatism (SIA) Surgically induced astigmatism was presented in dioptres at each visit. Visits 1-3 No
Secondary Surgically Induced Astigmatism (SIA) Surgically induced astigmatism presented in dioptres at each visit. Visits 4-8 No
See also
  Status Clinical Trial Phase
Completed NCT04685538 - Chloroprocaine 3% Gel Eye Drop as Topical Anestheticsin Phacoemulsification. Phase 3
Recruiting NCT06060041 - IC-8 Apthera IOL New Enrollment Post Approval Study
Recruiting NCT05518539 - Evaluation of Quality of Vision and Visual Outcomes With Bilateral Implantation of the Clareon PanOptix Intraocular Lens
Recruiting NCT05271942 - Tilt and Tumble vs Divide and Conquer - a Unique Comparison of the Two Cataract Surgery Methods N/A
Active, not recruiting NCT04778501 - PMCF Study on Monofocal Toric IOL (PODEYE TORIC) in Asia N/A
Completed NCT05062564 - Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye N/A
Completed NCT03751033 - Influence of DisCoVisc Ophthalmic Viscosurgical Device (OVD) on Intraoperative Aberrometry Readings N/A
Completed NCT02529488 - Investigation of AcrySof® IQ PanOptix™ Presbyopia-Correcting Intraocular Lens (IOL) Model TFNT00 N/A
Completed NCT04539548 - A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract Phase 3
Completed NCT03740659 - Evaluation Of Aqueous Humor Of Levofloxacin-Dexamethasone Eye Drops And Of Its Components In Patients Undergoing Cataract Surgery Phase 2
Completed NCT03494257 - Effect of Fixed Brinzolamide-brimonidine Combination on Intraocular Pressure After Phacoemulsification N/A
Completed NCT05119127 - Rotational Stability of Acrysof IQ Vivity Extended Vision Toric IOL and Refractive Visual Outcome. N/A
Active, not recruiting NCT04271709 - Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT) N/A
Recruiting NCT03713268 - Intraoperative OCT Guidance of Intraocular Surgery II
Completed NCT03739528 - Levo-Dexa vs. Tobra+Dexa for Prevention and Treatment of Inflammation and Prevention of Infection in Cataract Surgery Phase 3
Completed NCT02888210 - A Study Assessing Safety and Efficacy of MD-15 Intraocular Lens in Patients With Aphakic Eye After Cataract Surgery Phase 3
Completed NCT03356847 - Evaluation of the Rotational Stability of the Monofocal SISA Implant Following Cataract Surgery N/A
Completed NCT04332640 - Clinical Evaluation of the Next Generation Phaco System N/A
Recruiting NCT03638726 - Subconjunctival Atropine and Intracameral Epinephrine for Pupil Dilation in Phacoemulsification Phase 4
Completed NCT03050697 - Evaluation of the Safety and Performance of the HARMONI® Toric Lens N/A